April19 Overview
- Year Founded
-
2020
- Status
-
Out of Business
- Employees
-
5
- Latest Deal Type
-
Out of Business
April19 General Information
Description
Developer of an AI-driven drug-discovery technology designed to focus on developing and screening novel compounds for psychedelic medicine. The company uses machine learning to find novel psychedelic drug compounds, aiming to minimize adverse effects and maximize the clinical benefits of the drugs, enabling scientists to unlock the kaleidoscope of untapped possibilities in psychedelic medicine.
Contact Information
Website
www.april19.aiCorporate Office
- Elsley Court, 20-22 Great Titchfield Street
- London W1W 8BE
- England, United Kingdom
Corporate Office
- Elsley Court, 20-22 Great Titchfield Street
- London W1W 8BE
- England, United Kingdom
April19 Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Out of Business | 12-Mar-2024 | Completed | Out of Business | |||
| 1. Seed Round | 04-May-2021 | Completed | Generating Revenue |
April19 Signals
April19 FAQs
-
When was April19 founded?
April19 was founded in 2020.
-
Where is April19 headquartered?
April19 is headquartered in London, United Kingdom.
-
What is the size of April19?
April19 has 5 total employees.
-
What industry is April19 in?
April19’s primary industry is Drug Discovery.
-
Is April19 a private or public company?
April19 is a Private company.
-
What is April19’s current revenue?
The current revenue for April19 is .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process